Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Bergamaschi
Pnd72 - Cost-Minimization Analysis of Teriflunomide and Dimethyl Fumarate for Treatment of Relapsing-Remitting Forms of Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Polyspecific, Antiviral Immune Response Distinguishes Multiple Sclerosis and Neuromyelitis Optica
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Related publications
Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
Farmeconomia. Health economics and therapeutic pathways
Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis
Neurology and Therapy
Neurology
Mixed Treatment Comparison of Adverse Events for BG-12, Glatiramer, and Teriflunomide for the Treatment of Relapsing Forms of Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
Dimethyl Fumarate for Relapsingremitting Multiple Sclerosis
Prescriber
Pharmacology
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Intravenous Immunoglobulin G for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis
European Journal of Neurology
Neurology
